Evidence map›Paper›PMID 29217760›Full record

ArticleCancer research2018

Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.

Aaron J Grossberg, Elisabeth G Vichaya, Diana L Christian, Jessica M Molkentine, Daniel W Vermeer, Phillip S Gross, Paola D Vermeer, John H Lee, Robert Dantzer

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The metabolic basis of cancer-related fatigue.Neuroscience and biobehavioral reviews · 2025
    Review
  9. Article
  10. [Immunological aspects and stress regulation in fatigue].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Review
  11. Article
  12. Article
  13. Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma.American journal of physiology. Endocrinology and metabolism · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Aaron J GrossbergDepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas. agrossberg@mdanderson.org.
Elisabeth G VichayaDepartment of Symptom Research, MD Anderson Cancer Center, Houston, Texas.
Diana L ChristianDepartment of Symptom Research, MD Anderson Cancer Center, Houston, Texas.
Jessica M MolkentineDepartment of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.
Daniel W VermeerCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota.
Phillip S GrossDepartment of Symptom Research, MD Anderson Cancer Center, Houston, Texas.
Paola D VermeerCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota.
John H LeeCancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota.
Robert DantzerDepartment of Symptom Research, MD Anderson Cancer Center, Houston, Texas.
The University of Texas MD Anderson Cancer Center · USSanford Research · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
The Metabolic Basis of Cancer-Related FatigueR01CA193522 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANTZER, ROBERT · 2015 to 2023
$3.8M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA193522
6 · The paper itself

Abstract

Fatigue is the most common symptom of cancer at diagnosis, yet causes and effective treatments remain elusive. As tumors can be highly inflammatory, it is generally accepted that inflammation mediates cancer-related fatigue. However, evidence to support this assertion is mostly correlational. In this study, we directly tested the hypothesis that fatigue results from propagation of tumor-induced inflammation to the brain and activation of the central proinflammatory cytokine, IL1. The heterotopic syngeneic murine head and neck cancer model (mEER) caused systemic inflammation and increased expression of

Indexed as

AnimalsBrainCytokinesDisease Models, AnimalFatigueHead and Neck NeoplasmsInflammationInterleukin-1betaMaleMiceMice, Inbred C57BLMice, KnockoutMotor ActivityMyeloid Differentiation Factor 88Receptors, Interleukin-1 Type ISignal TransductionCytokinesIL1B protein, mouseIL1R1 protein, mouseInterleukin-1betaMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Interleukin-1 Type I

Identifiers

PMID29217760
PMCPMC5811314
OpenAlexW2790831669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.